MedTrace Logo

Impact of Early Intensive Stimulation on Bimanual Function in Infants at High Risk of Unilateral CP (BB-BIM)

NCT04899284 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-05-26

No results posted yet for this study

Summary

The aim of this study is to measure the impact of early bimanual stimulation in babies with clinical signs of underuse of one hand. The observation focuses on the developmental curve of hands use. The intervention is provided by the family environment and takes place in the child's familiar surroundings.

Conditions

  • Cerebral Palsy

Interventions

OTHER

Early Intensive Bimanual Stimulation

Early intensive bimanual stimulation program for infants showing early signs of UCP, delivered by the family environment, in the child's familiar surroundings, under the guidance of a therapist, over a period of 2 months.

Sponsors & Collaborators

  • Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL) - France

    collaborator UNKNOWN

  • Hospices Civils de Lyon

    collaborator OTHER

  • Laboratoire de Biomécanique et Mécanique des Chocs (LBMC) - France

    collaborator UNKNOWN

  • Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française

    lead OTHER

Principal Investigators

  • Rachel Bard-Pondarré, OT · Croix rouge française Centre Médico-Chirurgical de Réadaptation des Massues. Lyon, France

  • Emmanuelle Chaléat-Valayer, PhD · Croix rouge française Centre Médico-Chirurgical de Réadaptation des Massues. Lyon, France

  • Carole Vuillerot, PhD · Hopital Femme Mère Enfant, l'Escale MPR pédiatrique (Hospices Civils de Lyon). Bron, France

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-21
Primary Completion
2021-05-01
Completion
2022-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899284 on ClinicalTrials.gov